QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques-Reference-Cited by-同舟云学术

QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques

Published:2017-11-08 Issue:3 Volume:44 Page:407-420
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Beg Sarwar¹,Saini Sumant¹,Bandopadhyay Shantanu¹,Katare O. P.¹,Singh Bhupinder¹²

Affiliation:

1. UGC Centre of Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India;

2. UGC-Centre of Excellence in Applications of Nanomaterials, Nanoparticles and Nanocomposites (Biomedical Sciences), Panjab University, Chandigarh, India

Funder

University Grants Commission

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2017.1395459

Reference37 articles.

1. Approaches to Oral Drug Delivery for Challenging Molecules

2. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

3. Bioavailability Enhancement Strategies: Basics, Formulation Approaches and Regulatory Considerations

4. When poor solubility becomes an issue: From early stage to proof of concept

5. Oral Lipid Based Drug Delivery System (LBDDS): Formulation, Characterization and Application: A Review

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating the use of the target product profile in academic research: a systematic review;Journal of Translational Medicine;2024-07-29

2. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles;Therapeutic Delivery;2024-05-09

3. Quality by Design Topical Formulations;Introduction to Quality by Design (QbD);2024

4. Quality by Design in Relation to Clinical Trials;Introduction to Quality by Design (QbD);2024

5. Quality by design engineered, enhanced anticancer activity of temozolomide and resveratrol coloaded NLC and brain targeting via lactoferrin conjugation in treatment of glioblastoma;European Journal of Pharmaceutics and Biopharmaceutics;2023-10